NCT06134141

Brief Summary

Describe demographic and clinical data of infant and pediatric with cardiac catheterization who admitted to cardiology unit of Assiut university children hospital Asses outcome of cardiac catheterization in pediatric and infant at AUCH

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2023

Completed
11 days until next milestone

Study Start

First participant enrolled

November 17, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

November 6, 2023

Last Update Submit

November 20, 2023

Conditions

Cardiac Catheterization

Outcome Measures

Primary Outcomes (1)

  • procedure time [ Time Frame: duration of the cardiac catheterization procedure (1-4 hours depending on complexity of case) ]

    duration of the cardiac catheterization procedure (1-4 hours depending on complexity of case\|)

    Baseline

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

children aged 1 month to 18 years old that underwent cardiac catheterization for congenital heart disease management.

You may qualify if:

  • children aged 1 month to 18 years old that underwent cardiac catheterization for congenital heart disease management.

You may not qualify if:

  • Neonate aged less than 1 month and adult \>16 years old 2-Patients with chronic renal and hepatic disease could affect results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Crystal MA, Ing FF. Pediatric interventional cardiology: 2009. Curr Opin Pediatr. 2010 Oct;22(5):567-72. doi: 10.1097/MOP.0b013e32833e1328.

    PMID: 20733492BACKGROUND

  • Moustafa GA, Kolokythas A, Charitakis K, Avgerinos DV. Therapeutic Utilities of Pediatric Cardiac Catheterization. Curr Cardiol Rev. 2016;12(4):258-269. doi: 10.2174/1573403x12666160301121253.

    PMID: 26926291BACKGROUND

  • Backes CH, Cheatham SL, Deyo GM, Leopold S, Ball MK, Smith CV, Garg V, Holzer RJ, Cheatham JP, Berman DP. Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications. J Am Heart Assoc. 2016 Feb 12;5(2):e002923. doi: 10.1161/JAHA.115.002923.

    PMID: 26873689BACKGROUND

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
71515,Assiut

Study Record Dates

First Submitted

November 6, 2023

First Posted

November 18, 2023

Study Start

November 17, 2023

Primary Completion

December 31, 2024

Study Completion

March 31, 2025

Last Updated

November 22, 2023

Record last verified: 2023-11